Back to top
more

CareDx (CDNA)

(Delayed Data from NSDQ)

$8.95 USD

8.95
706,618

+0.12 (1.36%)

Updated Mar 24, 2023 04:00 PM ET

After-Market: $8.96 +0.01 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.52%
2Buy18.26%
3Hold9.60%
4Sell5.38%
5Strong Sell2.61%
S&P50010.68%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (144 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CDNA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for CareDx, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 293 348 225 38 65
Receivables 66 60 35 24 10
Notes Receivable 0 0 0 0 0
Inventories 19 17 10 6 5
Other Current Assets 9 8 4 4 2
Total Current Assets 388 433 273 72 81
Net Property & Equipment 36 22 11 4 4
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 81 87 68 69 45
Deposits & Other Assets 4 6 1 1 0
Total Assets 543 567 369 152 131
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 0 0 0 0 0
Accounts Payable 10 13 10 6 5
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 66 64 39 29 15
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 21 0 0
Total Current Liabilities 76 77 69 35 20
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 1 2 4
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 3 6 4 16 11
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 112 101 91 53 35
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 899 854 632 438 412
Retained Earnings -460 -383 -353 -334 -312
Other Equity -8 -5 -2 -5 -4
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 431 466 278 99 96
Total Liabilities & Shareholder's Equity 543 567 369 152 131
Total Common Equity 431 466 278 99 96
Shares Outstanding 53.50 52.80 49.20 42.40 38.90
Book Value Per Share 8.05 8.82 5.64 2.33 2.47

Fiscal Year End for CareDx, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Assets          
Cash & Equivalents 293 291 306 319 348
Receivables 66 70 70 65 60
Notes Receivable 0 0 0 0 0
Inventories 19 18 19 18 17
Other Current Assets 9 8 9 9 8
Total Current Assets 388 388 404 411 433
Net Property & Equipment 36 34 33 28 22
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 81 81 83 85 87
Deposits & Other Assets 4 5 5 5 6
Total Assets 543 545 541 547 567
Liabilities & Shareholders Equity 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Notes Payable 0 0 0 0 0
Accounts Payable 10 11 17 11 13
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 66 60 62 56 64
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 76 70 78 67 77
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 5 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 3 3 0 6
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 112 108 98 89 101
Shareholders Equity 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 899 887 875 865 854
Retained Earnings -460 -441 -425 -403 -383
Other Equity -8 -9 -7 -5 -5
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 431 437 444 458 466
Total Liabilities & Shareholder's Equity 543 545 541 547 567
Total Common Equity 431 437 444 458 466
Shares Outstanding 53.50 53.40 53.20 53.20 52.80
Book Value Per Share 8.05 8.18 8.34 8.60 8.82